NOVANTRONE Side Effects

6906045-1 | Acute Leukaemia
on Jul 16, 2010 Male patient from CANADA , 58 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Novantrone (View Usage). Patient experienced the following unwanted or unexpected effects: acute leukaemia. Novantrone dosage: .

6905972-9 | Acute Leukaemia
Patient was taking Novantrone (View Usage). Patient had the following side effects: acute leukaemia on Jul 16, 2010 from CANADA Additional patient health information: Female patient , 46 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Novantrone dosage: .

6905617-8 | Acute Leukaemia
Adverse event was reported on Jul 16, 2010 by a Male patient taking Novantrone (View Usage) (Dosage: ) was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Location: UNITED STATES , 28 years of age, After Novantrone was administered, patient had the following side effects: acute leukaemia.

6831166-1 | Dysarthria, Musculoskeletal Disorder, Thyroid Disorder, Weight Increased
on Jun 24, 2010 Female patient from UNITED STATES , 39 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Novantrone (View Usage). Patient experienced the following unwanted or unexpected effects: dysarthria, musculoskeletal disorder, thyroid disorder, weight increased. Novantrone dosage: .


6819147-5 | Cardiac Disorder, Diastolic Dysfunction, Ejection Fraction Decreased, Left Ventricular Dysfunction, Myocardial Infarction
on Jun 21, 2010 Male patient from UNITED STATES , 66 years of age, weighting 134.5 lb, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Novantrone (View Usage). Patient had the following side effects: cardiac disorder, diastolic dysfunction, ejection fraction decreased, left ventricular dysfunction, myocardial infarction. Novantrone dosage: 12 Mg/m2, 1 In 3 M, Intravenous (not Otherwise Specified). During the same period patient was treated with HYZAAR (View Hyzaar Review and Hyzaar Label ), GLIPIZIDE (View Glipizide Review and Glipizide Label ), ALTACE (View Altace Review and Altace Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), LIPITOR (View Lipitor Review and Lipitor Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ).

6819114-1 | Cardiac Failure Congestive, Cardiomyopathy
Patient was taking Novantrone (View Usage). After Novantrone was administered, patient had the following side effects: cardiac failure congestive, cardiomyopathy (What is cardiomyopathy?) on Jun 21, 2010 from UNITED STATES Additional patient health information: Female patient , 45 years of age, . Novantrone dosage: . During the same period patient was treated with REBIF (8.8 Mcg) (View Rebif Review and Rebif Label ). Patient was hospitalized.

6763699-0 | Activated Partial Thromboplastin Time Prolonged, Asthenia, Blood Creatinine Increased, Blood Glucose Increased, Blood Pressure Systolic Increased, Blood Urea Increased, Chest Pain, Dyspnoea Exertional, Haematocrit Decreased
Adverse event was reported on May 26, 2010 by a Male patient taking Novantrone (View Usage) (Dosage: 21 Mg, 1 In 21 D, Intravenous (not Otherwise Specified)) was diagnosed with prostate cancer metastatic and. Location: UNITED STATES , 79 years of age, weighting 141.3 lb, Patient experienced the following unwanted or unexpected effects: activated partial thromboplastin time prolonged, asthenia, blood creatinine increased, blood glucose increased, blood pressure systolic increased, blood urea increased, chest pain (What is chest pain?), dyspnoea exertional, haematocrit decreased. During the same period patient was treated with PREDNISONE TAB (5 Mg, 2 In 1 D, Oral) (View Prednisone Tab Review and Prednisone Tab Label ), ASTEPRO (View Astepro Review and Astepro Label ), MEGESTROL ACETATE (View Megestrol Acetate Review and Megestrol Acetate Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), LISINOPRIL (LISINOPRIL DIHYDRATE) (View Lisinopril (lisinopril Dihydrate) Review and Lisinopril (lisinopril Dihydrate) Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CENTRUM SILVER (CENTRUM SILVER /01292501/) (View Centrum Silver (centrum Silver /01292501/) Review and Centrum Silver (centrum Silver /01292501/) Label ). Patient was hospitalized.

6759870-4 | Cardiac Disorder, Infection, Respiratory Failure
on May 24, 2010 Female patient from UNITED STATES , 43 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Novantrone (View Usage). Patient had the following side effects: cardiac disorder, infection (What is infection?), respiratory failure. Novantrone dosage: . During the same period patient was treated with STEROIDS (CORTICOSTEROIDS) (View Steroids (corticosteroids) Review and Steroids (corticosteroids) Label ).

6759537-2 | Acute Myeloid Leukaemia
on May 21, 2010 Male patient from UNITED STATES , 44 years of age, weighting 286.6 lb, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Novantrone (View Usage). After Novantrone was administered, patient had the following side effects: acute myeloid leukaemia. Novantrone dosage: 1 In 3 M, Intravenous. During the same period patient was treated with COPAXONE (View Copaxone Review and Copaxone Label ).

6739552-5 | Arrhythmia
Patient was taking Novantrone (View Usage). Patient experienced the following unwanted or unexpected effects: arrhythmia (What is arrhythmia?) on May 10, 2010 from UNITED STATES Additional patient health information: Female patient , 59 years of age, . Novantrone dosage: .

6733663-6 | Activated Partial Thromboplastin Time Prolonged, Aortic Valve Incompetence, Aortic Valve Sclerosis, Atrial Fibrillation, Blood Urea Increased, Breath Sounds Abnormal, Cardiac Murmur, Cardiomegaly, Dilatation Ventricular
Adverse event was reported on May 06, 2010 by a Male patient taking Novantrone (View Usage) (Dosage: 24 Mg, 1 In 21 D, Intravenous (not Otherwise Specified)) was diagnosed with prostate cancer metastatic and. Location: UNITED STATES , 73 years of age, weighting 224.9 lb, Patient had the following side effects: activated partial thromboplastin time prolonged, aortic valve incompetence, aortic valve sclerosis, atrial fibrillation (What is atrial fibrillation?), blood urea increased, breath sounds abnormal, cardiac murmur, cardiomegaly, dilatation ventricular. During the same period patient was treated with PREDNISONE TAB (10 Mg, 2 In 1 D, Oral) (View Prednisone Tab Review and Prednisone Tab Label ), CENTRUM SILVER (CENTRUM SILVER /01292501/) (View Centrum Silver (centrum Silver /01292501/) Review and Centrum Silver (centrum Silver /01292501/) Label ), COLACE (DOCUSATE SODIUM) (View Colace (docusate Sodium) Review and Colace (docusate Sodium) Label ), CARAFATE (View Carafate Review and Carafate Label ), NEXIUM (View Nexium Review and Nexium Label ), CRESTOR (View Crestor Review and Crestor Label ), DIOVAN (View Diovan Review and Diovan Label ). Patient was hospitalized.

6728385-1 | Ejection Fraction Decreased
on Apr 30, 2010 Female patient from UNITED STATES , 40 years of age, weighting 180.8 lb, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Novantrone (View Usage). After Novantrone was administered, patient had the following side effects: ejection fraction decreased. Novantrone dosage: .

6724166-3 | Fatigue, Infusion Related Reaction, Vomiting
on Apr 26, 2010 Male patient from UNITED STATES , 50 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Novantrone (View Usage). Patient experienced the following unwanted or unexpected effects: fatigue, infusion related reaction, vomiting. Novantrone dosage: .

6699423-X | Bacterial Infection, Cardiovascular Disorder, Culture Wound Positive, Incontinence, Infusion Site Extravasation, Injection Site Abscess, Injection Site Discolouration, Injection Site Erythema, Injection Site Induration
Patient was taking Novantrone (View Usage). Patient had the following side effects: bacterial infection (What is bacterial infection?), cardiovascular disorder, culture wound positive, incontinence, infusion site extravasation, injection site abscess, injection site discolouration, injection site erythema, injection site induration on Apr 12, 2010 from UNITED STATES Additional patient health information: Male patient , 56 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Novantrone dosage: .

6669253-3 | Cardiac Disorder
Adverse event was reported on Mar 23, 2010 by a Female patient taking Novantrone (View Usage) (Dosage: ) was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Location: UNITED STATES , 48 years of age, After Novantrone was administered, patient had the following side effects: cardiac disorder.

6665799-2 | Activated Partial Thromboplastin Time Prolonged, Anxiety, Cancer Pain, Coagulopathy, Cyanosis, Dehydration, Disseminated Intravascular Coagulation, Dyspnoea, Haematocrit Decreased
on Mar 19, 2010 Male patient from UNITED STATES , 64 years of age, weighting 152.1 lb, was diagnosed with prostate cancer metastatic and was treated with Novantrone (View Usage). Patient experienced the following unwanted or unexpected effects: activated partial thromboplastin time prolonged, anxiety (What is anxiety?), cancer pain, coagulopathy, cyanosis, dehydration, disseminated intravascular coagulation, dyspnoea, haematocrit decreased. Novantrone dosage: 22 Mg, 1 In 21 Days, Intravenous (not Otherwise Specified). During the same period patient was treated with PREDNISONE TAB (10 Mg, 1 In 1 Days, Oral) (View Prednisone Tab Review and Prednisone Tab Label ), PROMETHAZINE (View Promethazine Review and Promethazine Label ), REGLAN (METCLOPRAMIDE) (View Reglan (metclopramide) Review and Reglan (metclopramide) Label ), MIRALAX (View Miralax Review and Miralax Label ), BACTRIM (View Bactrim Review and Bactrim Label ), SENOKOT (SENNA ALEXANDRINA) (View Senokot (senna Alexandrina) Review and Senokot (senna Alexandrina) Label ), MORPHINE (View Morphine Review and Morphine Label ). Patient was hospitalized.

6665799-2 | Activated Partial Thromboplastin Time Prolonged, Anxiety, Cancer Pain, Coagulopathy, Cyanosis, Dehydration, Disseminated Intravascular Coagulation, Dyspnoea, Haematocrit Decreased
on Mar 19, 2010 Male patient from UNITED STATES , 64 years of age, weighting 152.1 lb, was diagnosed with prostate cancer metastatic and was treated with Novantrone (View Usage). Patient had the following side effects: activated partial thromboplastin time prolonged, anxiety (What is anxiety?), cancer pain, coagulopathy, cyanosis, dehydration, disseminated intravascular coagulation, dyspnoea, haematocrit decreased. Novantrone dosage: 22 Mg, 1 In 21 Days, Intravenous (not Otherwise Specified). During the same period patient was treated with PREDNISONE TAB (10 Mg, 1 In 1 Days, Oral) (View Prednisone Tab Review and Prednisone Tab Label ), PROMETHAZINE (View Promethazine Review and Promethazine Label ), REGLAN (View Reglan Review and Reglan Label ), MIRALAX (View Miralax Review and Miralax Label ), BACTRIM (View Bactrim Review and Bactrim Label ), SENOKOT (SENNA ALEXANDRINA) (View Senokot (senna Alexandrina) Review and Senokot (senna Alexandrina) Label ), MORPHINE (View Morphine Review and Morphine Label ). Patient was hospitalized.

6649415-1 | Convulsion
Patient was taking Novantrone (View Usage). After Novantrone was administered, patient had the following side effects: convulsion on Mar 09, 2010 from UNITED STATES Additional patient health information: Female patient , 49 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Novantrone dosage: As Required.

6648165-5 | Bladder Transitional Cell Carcinoma, Calculus Bladder, Urinary Tract Infection
Adverse event was reported on Mar 08, 2010 by a Male patient taking Novantrone (View Usage) (Dosage: 12 Mg/m2, Intravenous) was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Location: UNITED STATES , 63 years of age, weighting 160.9 lb, Patient experienced the following unwanted or unexpected effects: bladder transitional cell carcinoma, calculus bladder, urinary tract infection (What is urinary tract infection?). During the same period patient was treated with TYSABRI (300 Mg, 1 In 1 Months, Intravenous (not Otherwise Specified)) (View Tysabri Review and Tysabri Label ).

6636092-9 | Ejection Fraction Decreased
on Feb 26, 2010 Female patient from UNITED STATES , 52 years of age, weighting 174.2 lb, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Novantrone (View Usage). Patient had the following side effects: ejection fraction decreased. Novantrone dosage: 24 Mg, 1 In 3 Months, Intravenous (not Otherwise Specified). During the same period patient was treated with REBIF (44 Mcg, 3 In 1 Weeks, Subcutaneous) (View Rebif Review and Rebif Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), LOPERAMIDE (LOPERAMIODE HYDROCHLORIDE) (View Loperamide (loperamiode Hydrochloride) Review and Loperamide (loperamiode Hydrochloride) Label ), ZOCOR (View Zocor Review and Zocor Label ), ACTOS (View Actos Review and Actos Label ), LOTREL (LOTREL /01289101/) (View Lotrel (lotrel /01289101/) Review and Lotrel (lotrel /01289101/) Label ), TYLENOL (View Tylenol Review and Tylenol Label ).

6631154-4 | Ejection Fraction Decreased, Supraventricular Tachycardia, Wheezing
on Feb 23, 2010 Male patient from UNITED STATES , 49 years of age, weighting 224.9 lb, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Novantrone (View Usage). After Novantrone was administered, patient had the following side effects: ejection fraction decreased, supraventricular tachycardia, wheezing. Novantrone dosage: See Image. During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ), TRILEPTAL (View Trileptal Review and Trileptal Label ).

6631124-6 | Cardiac Arrest, Myocardial Infarction
Patient was taking Novantrone (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), myocardial infarction on Feb 25, 2010 from UNITED STATES Additional patient health information: Female patient , 49 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Novantrone dosage: 1 In Three Months, Intravenous (not Otherwise Specified). During the same period patient was treated with REBIF (44 Mcg, 3 In 1 Weeks, Subcutaneous) (View Rebif Review and Rebif Label ).

6631068-X | Malaise, Multiple Gated Acquisition Scan Abnormal, Nausea, Weight Decreased, White Blood Cell Count Decreased
Adverse event was reported on Feb 24, 2010 by a Female patient taking Novantrone (View Usage) (Dosage: 1 In 3 Months, Intravenous (not Otherwise Specified)) was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Location: UNITED STATES , 39 years of age, weighting 160.9 lb, Patient had the following side effects: malaise, multiple gated acquisition scan abnormal, nausea (What is nausea?), weight decreased, white blood cell count decreased. During the same period patient was treated with BACLOFEN (View Baclofen Review and Baclofen Label ).

6619206-6 | Breast Cancer In Situ, Breast Prosthesis User, Connective Tissue Disorder, Device Dislocation, Graft Infection, Implant Site Reaction, Nipple Infection, Transplant
on Feb 17, 2010 Female patient from UNITED STATES , 45 years of age, weighting 114.6 lb, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Novantrone (View Usage). After Novantrone was administered, patient had the following side effects: breast cancer in situ, breast prosthesis user, connective tissue disorder (What is connective tissue disorder?), device dislocation, graft infection, implant site reaction, nipple infection, transplant. Novantrone dosage: Intravenous (not Otherwise Specified). During the same period patient was treated with KEPPRA (View Keppra Review and Keppra Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), PROVIGIL (View Provigil Review and Provigil Label ), LORTAB (VICODIN) (View Lortab (vicodin) Review and Lortab (vicodin) Label ), WELLBUTRIN (View Wellbutrin Review and Wellbutrin Label ), REBIF (View Rebif Review and Rebif Label ). Patient was hospitalized.

6616965-3 | Acute Promyelocytic Leukaemia, Dehydration, Infection, Pancytopenia
on Feb 23, 2010 Female patient from FRANCE , 49 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Novantrone (View Usage). Patient experienced the following unwanted or unexpected effects: acute promyelocytic leukaemia, dehydration, infection (What is infection?), pancytopenia. Novantrone dosage: 20 Mg, Not Reported, Intravenous. During the same period patient was treated with AVONEX (Intra-muscular) (View Avonex Review and Avonex Label ), REBIF (44 Mcg, 1 In 1 3 Weeks, Subcutaneous) (View Rebif Review and Rebif Label ), ANETHOLE TRITHIONE (View Anethole Trithione Review and Anethole Trithione Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), OXYBUTYNIN CHLORIDE (View Oxybutynin Chloride Review and Oxybutynin Chloride Label ), BACLOFEN (View Baclofen Review and Baclofen Label ), TOCOPHEROL CONCENTRATE CAP (View Tocopherol Concentrate Cap Review and Tocopherol Concentrate Cap Label ).

6614637-2 | Bladder Transitional Cell Carcinoma, Calculus Bladder, Urinary Tract Infection
Patient was taking Novantrone (View Usage). Patient had the following side effects: bladder transitional cell carcinoma, calculus bladder, urinary tract infection (What is urinary tract infection?) on Feb 12, 2010 from UNITED STATES Additional patient health information: Male patient , 63 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Novantrone dosage: Intravenous (not Otherwise Specified). During the same period patient was treated with TYSABRI (300 Mg, 1 In 1 Months, Intravenous (not Otherwise Specified)) (View Tysabri Review and Tysabri Label ).

6608688-1 | Dyspnoea, Ejection Fraction Decreased, Fatigue
Adverse event was reported on Feb 11, 2010 by a Female patient taking Novantrone (View Usage) (Dosage: 12 Mg/m2, Not Reported, Not Reported 5 Mg/m2, Not Reported, Not Reported 8 Mg/m2, Not Reported, Not) was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Location: UNITED STATES , 29 years of age, weighting 205.0 lb, After Novantrone was administered, patient had the following side effects: dyspnoea, ejection fraction decreased, fatigue. During the same period patient was treated with GABAPENTIN (View Gabapentin Review and Gabapentin Label ), ORTHO TRI CYCLEN (View Ortho Tri-cyclen Review and Ortho Tri-cyclen Label ).

6599650-6 | Multiple Sclerosis Relapse, Optic Neuritis
on Feb 03, 2010 Female patient from UNITED STATES , 38 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Novantrone (View Usage). Patient experienced the following unwanted or unexpected effects: multiple sclerosis relapse, optic neuritis. Novantrone dosage: Intravenous (not Otherwise Specified). During the same period patient was treated with NEIRONTIN (GABAPENTIN) (View Neirontin (gabapentin) Review and Neirontin (gabapentin) Label ), BACLOFEN (View Baclofen Review and Baclofen Label ). Patient was hospitalized and became disabled.

6586313-6 | Mental Impairment
on Feb 16, 2010 Female patient from UNITED STATES , weighting 150.0 lb, was treated with Novantrone (View Usage). Patient had the following side effects: mental impairment. Novantrone dosage: . Patient was hospitalized.

6584895-1 | Condition Aggravated, Incontinence, Injection Site Discolouration, Injection Site Erythema, Injection Site Extravasation, Injection Site Induration, Injection Site Infection, Injection Site Pustule, Injection Site Reaction
Patient was taking Novantrone (View Usage). After Novantrone was administered, patient had the following side effects: condition aggravated, incontinence, injection site discolouration, injection site erythema, injection site extravasation, injection site induration, injection site infection, injection site pustule, injection site reaction on Jan 02, 2010 from UNITED STATES Additional patient health information: Male patient , 56 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Novantrone dosage: 1 In 3 Months, Intravenous (not Otherwise Specified).

6573493-1 | Dental Caries, Premature Menopause
Adverse event was reported on Feb 04, 2010 by a Female patient taking Novantrone (View Usage) (Dosage: ) was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Location: UNITED STATES , 47 years of age, weighting 180.3 lb, Patient experienced the following unwanted or unexpected effects: dental caries, premature menopause.

6554900-7 | Dyspnoea, Ejection Fraction Decreased, Fatigue
on Jan 12, 2010 Female patient from UNITED STATES , 29 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Novantrone (View Usage). Patient had the following side effects: dyspnoea, ejection fraction decreased, fatigue. Novantrone dosage: .

6553826-2 | Cardiac Disorder
on Jan 11, 2010 Female patient from UNITED STATES , 52 years of age, weighting 174.2 lb, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Novantrone (View Usage). After Novantrone was administered, patient had the following side effects: cardiac disorder. Novantrone dosage: 24 Mg, 1 In 3 Months, Intravenous. During the same period patient was treated with REBIF (44 Mcg, 3 In 1 Weeks, Subcutaneous) (View Rebif Review and Rebif Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), LOPERAMIDE (View Loperamide Review and Loperamide Label ), ZOCOR (View Zocor Review and Zocor Label ), ACTOS (View Actos Review and Actos Label ), LOTREL (View Lotrel Review and Lotrel Label ), TYLENOL (View Tylenol Review and Tylenol Label ).

6539400-2 | Abnormal Behaviour, Asthenia, Cardiac Disorder, Ejection Fraction Decreased, Wound Infection
Patient was taking Novantrone (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal behaviour, asthenia, cardiac disorder, ejection fraction decreased, wound infection on Dec 29, 2009 from UNITED STATES Additional patient health information: Female patient , 44 years of age, weighting 185.2 lb, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Novantrone dosage: 12 Mg/m2, Intravenous (not Otherwise Specified). During the same period patient was treated with REBIF (44 Mcg, 3 In 1 Weeks, Subcutaneous) (View Rebif Review and Rebif Label ), BACLOFEN (View Baclofen Review and Baclofen Label ). Patient was hospitalized.

6537275-9 | Asthenia, Dysarthria, Dysstasia, Eye Pain, Facial Palsy, Gait Disturbance, Headache, Hemiplegia, Mental Status Changes
Adverse event was reported on Dec 28, 2009 by a Female patient taking Novantrone (View Usage) (Dosage: 12 Mg/m2, 1 In 3 Months) was diagnosed with off label use and. Location: UNITED STATES , 17 years of age, weighting 145.5 lb, Patient had the following side effects: asthenia, dysarthria, dysstasia, eye pain, facial palsy, gait disturbance, headache (What is headache?), hemiplegia, mental status changes. During the same period patient was treated with BETASERON (View Betaseron Review and Betaseron Label ), TOPAMAX (View Topamax Review and Topamax Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), BACLOFEN (View Baclofen Review and Baclofen Label ), PROVIGIL (View Provigil Review and Provigil Label ). Patient was hospitalized.

6526256-7 | Condition Aggravated, Ejection Fraction Decreased, Multiple Sclerosis
on Dec 18, 2009 Male patient from UNITED STATES , 45 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Novantrone (View Usage). After Novantrone was administered, patient had the following side effects: condition aggravated, ejection fraction decreased, multiple sclerosis (What is multiple sclerosis?). Novantrone dosage: 1 In 3 Months, Intravenous (not Otherwise Specified).

6523047-8 | Disease Progression, Dysphagia, Ejection Fraction Decreased, Interstitial Lung Disease, Multiple Sclerosis
on Dec 11, 2009 Female patient from UNITED STATES , 47 years of age, weighting 81.57 lb, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Novantrone (View Usage). Patient experienced the following unwanted or unexpected effects: disease progression, dysphagia, ejection fraction decreased, interstitial lung disease, multiple sclerosis (What is multiple sclerosis?). Novantrone dosage: Intravenous. During the same period patient was treated with REBIF (View Rebif Review and Rebif Label ). Patient was hospitalized.

6521191-2 | Abasia, Intestinal Obstruction
Patient was taking Novantrone (View Usage). Patient had the following side effects: abasia, intestinal obstruction on Dec 10, 2009 from UNITED STATES Additional patient health information: Female patient , 48 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Novantrone dosage: Not Reported, 1 In 3 Months, Subcutaneous. During the same period patient was treated with ZOFRAN (View Zofran Review and Zofran Label ). Patient was hospitalized.

6521177-8 | Blood Pressure Decreased, Ejection Fraction Decreased, Peripheral Coldness
Adverse event was reported on Dec 08, 2009 by a Female patient taking Novantrone (View Usage) (Dosage: 3 Cycle) was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Location: UNITED STATES , 50 years of age, After Novantrone was administered, patient had the following side effects: blood pressure decreased, ejection fraction decreased, peripheral coldness.

6506801-8 | Dyspepsia, Myocardial Infarction
on Dec 04, 2009 Male patient from UNITED STATES , 62 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Novantrone (View Usage). Patient experienced the following unwanted or unexpected effects: dyspepsia, myocardial infarction. Novantrone dosage: .

6493394-7 | Anxiety, Atrioventricular Block, Chest Discomfort, Malignant Melanoma, Pain In Extremity
on Nov 24, 2009 Female patient from UNITED STATES , 72 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Novantrone (View Usage). Patient had the following side effects: anxiety (What is anxiety?), atrioventricular block, chest discomfort, malignant melanoma, pain in extremity. Novantrone dosage: . During the same period patient was treated with REBIF (44 Mcg, 3 In 1 Weeks, Subcutaneous) (View Rebif Review and Rebif Label ), CRESTOR (View Crestor Review and Crestor Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ).

6492709-3 | Disease Progression, Ejection Fraction Decreased, Fall, Gait Disturbance, Lumbar Spinal Stenosis, Multiple Sclerosis, Sepsis, Spinal Compression Fracture
Patient was taking Novantrone (View Usage). After Novantrone was administered, patient had the following side effects: disease progression, ejection fraction decreased, fall (What is fall?), gait disturbance, lumbar spinal stenosis, multiple sclerosis (What is multiple sclerosis?), sepsis (What is sepsis?), spinal compression fracture on Nov 24, 2009 from UNITED STATES Additional patient health information: Female patient , 68 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Novantrone dosage: . During the same period patient was treated with AVONEX (View Avonex Review and Avonex Label ).

6492654-3 | Blood Disorder, Multiple Sclerosis
Adverse event was reported on Nov 30, 2009 by a Male patient taking Novantrone (View Usage) (Dosage: ) was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Location: UNITED STATES , 75 years of age, Patient experienced the following unwanted or unexpected effects: blood disorder, multiple sclerosis (What is multiple sclerosis?).

6480407-1 | Deep Vein Thrombosis, Leg Amputation, Localised Infection, Phlebitis, Skin Discolouration
on Nov 19, 2009 Male patient from UNITED STATES , 34 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Novantrone (View Usage). Patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), leg amputation, localised infection, phlebitis, skin discolouration. Novantrone dosage: 1 In 1 Days, Intravenous, 1 In 1 Days, Intravenous. Patient was hospitalized.

6465852-2 | Disease Progression, Ejection Fraction Decreased, Multiple Sclerosis, Sepsis, Spinal Column Stenosis, Spinal Compression Fracture
on Nov 17, 2009 Female patient from UNITED STATES , 68 years of age, was treated with Novantrone (View Usage). After Novantrone was administered, patient had the following side effects: disease progression, ejection fraction decreased, multiple sclerosis (What is multiple sclerosis?), sepsis (What is sepsis?), spinal column stenosis, spinal compression fracture. Novantrone dosage: . During the same period patient was treated with AVONEX (View Avonex Review and Avonex Label ).

6464973-8 | Abdominal Distension, Atrioventricular Block Second Degree, Cardiac Failure Congestive, Cardiac Ventricular Disorder, Hypotension, Joint Swelling, Muscle Spasms, Myocardial Oedema, Pericardial Effusion
Patient was taking Novantrone (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, atrioventricular block second degree, cardiac failure congestive, cardiac ventricular disorder, hypotension, joint swelling, muscle spasms, myocardial oedema, pericardial effusion on Nov 16, 2009 from UNITED STATES Additional patient health information: Female patient , 54 years of age, weighting 136.7 lb, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Novantrone dosage: 4 In 1 Years,. During the same period patient was treated with REBIF (44 Mcg, 3 In 1 Weeks,; 22 Mcg, 3 In 1 Weeks,) (View Rebif Review and Rebif Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), DIOVAN (View Diovan Review and Diovan Label ), LEVOTHROID (View Levothroid Review and Levothroid Label ), LIPITOR (View Lipitor Review and Lipitor Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), ALEVE (View Aleve Review and Aleve Label ), KLONOPIN (View Klonopin Review and Klonopin Label ).

6457172-7 | Condition Aggravated, Crohn's Disease, Respiratory Tract Infection
Adverse event was reported on Nov 09, 2009 by a Female patient taking Novantrone (View Usage) (Dosage: Mg/m2, Intravenous (not Otherwise Specified)) was diagnosed with multiple sclerosis (What is multiple sclerosis?), respiratory tract infection and. Location: UNITED STATES , 50 years of age, weighting 130.1 lb, Patient had the following side effects: condition aggravated, crohn's disease (What is crohn's disease?), respiratory tract infection. During the same period patient was treated with ZITHROMAX (View Zithromax Review and Zithromax Label ), XANAX (View Xanax Review and Xanax Label ), PROVIGIL (View Provigil Review and Provigil Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ), CYANOCOBALAMIN (View Cyanocobalamin Review and Cyanocobalamin Label ). Patient was hospitalized.

6443569-8 | Progressive Multiple Sclerosis
on Nov 02, 2009 Male patient from UNITED STATES , 58 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?), relapsing-remitting multiple sclerosis and was treated with Novantrone (View Usage). After Novantrone was administered, patient had the following side effects: progressive multiple sclerosis. Novantrone dosage: . During the same period patient was treated with TYSABRI (View Tysabri Review and Tysabri Label ).

6439443-3 | Decreased Appetite, Dehydration, Gastroenteritis Viral, Movement Disorder, Musculoskeletal Stiffness, Skin Discolouration
on Oct 27, 2009 Male patient from UNITED STATES , 58 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Novantrone (View Usage). Patient experienced the following unwanted or unexpected effects: decreased appetite, dehydration, gastroenteritis viral, movement disorder (What is movement disorder?), musculoskeletal stiffness, skin discolouration. Novantrone dosage: 1 In 3 Months. Patient was hospitalized.

6418809-1 | Fall, Wrist Fracture
Patient was taking Novantrone (View Usage). Patient had the following side effects: fall (What is fall?), wrist fracture on Oct 14, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 110.2 lb, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Novantrone dosage: 12 Mg/m2, 1 In 3 Months, Intravenous (not Otherwise Specified). During the same period patient was treated with FOSAMAX (View Fosamax Review and Fosamax Label ), OSCAL (CALCIUM CARBONATE) (View Oscal (calcium Carbonate) Review and Oscal (calcium Carbonate) Label ).